• OPEN AN ACCOUNT
Indian Indices
Nifty
24,718.60 -169.60
(-0.68%)
Sensex
81,118.60 -573.38
( -0.70%)
Bank Nifty
55,527.35 -555.20
( -0.99%)
Nifty IT
38,469.25 8.95
( 0.02%)
Global Indices
Nasdaq
42,986.19 99.41
(0.23%)
Dow Jones
6,065.31 22.07
(0.37%)
Hang Seng
37,801.43 -371.66
(-0.97%)
Nikkei 225
8,884.92 20.57
(0.23%)
Forex
USD-INR
85.49 -0.11
(-0.13%)
EUR-INR
97.91 0.18
(0.18%)
GBP-INR
115.53 -0.11
(-0.10%)
JPY-INR
0.59 0.00
(-0.16%)

EQUITY - MARKET SCREENER

Prime Fresh Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
540404
INE442V01012
51.0676805
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
28.68
254.02
EPS(TTM)
Face Value()
Div & Yield %
6.49
10
0.27
 

Indoco Remedies gains after receiving USFDA nod for Allopurinol drug
May 23,2025
Allopurinol is used to prevent or lower high uric acid levels in the blood. It is also used to prevent or lower excess uric acid levels caused by cancer medicines or in patients with kidney stones.

The drug is the generic equivalent of the reference listed drug (RLD), Zyloprim, marketed by Casper Pharma LLC.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs).

The pharmaceutical company reported a standalone net loss of Rs 10.23 crore in Q3 FY25 as against a net profit of Rs 20.01 crore posted in Q3 FY24. Revenue from operations stood at Rs 364.91 crore in the third quarter of FY25, down 18.61% as against Rs 448.38 crore posted in Q3 FY24.